Low Dose Cyclophosphamide Modulates Tumor Microenvironment by TGF-β Signaling Pathway

The tumor microenvironment has been recently recognized as a critical contributor to cancer progression and anticancer therapy-resistance. Cyclophosphamide (CTX) is a cytotoxic agent commonly used in clinics for the treatment of cancer. Previous reports demonstrated that CTX given at low continuous...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Hui, Lai, Yifan, Zhang, Rui, Daoud, Abdelkader, Feng, Qingyuan, Zhou, Jia, Shang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038197/
https://www.ncbi.nlm.nih.gov/pubmed/32023984
http://dx.doi.org/10.3390/ijms21030957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7038197/
https://www.ncbi.nlm.nih.gov/pubmed/32023984
http://dx.doi.org/10.3390/ijms21030957

Ejemplares similares